Article Text

Download PDFPDF
CASE REPORT
Rare side effect of adjuvant ipilimumab after surgical resection of melanoma: Guillain-Barré syndrome
  1. Rohini J Patel,
  2. Michael A Liu,
  3. Akshay Amaraneni,
  4. Simran K Sindhu
  1. Division of Hematology-Oncology, The University of Arizona Cancer Center, Tucson, Arizona, USA
  1. Correspondence to Rohini J Patel, rohinipatel{at}email.arizona.edu

Footnotes

  • Contributors RJP: analysis of current literature as it relates to case, drafting manuscript, critical revision of manuscript, final approval of version to be published. MAL: critical revision of manuscript, final approval of version to be published. AA: designed treatment plan and clinical recommendations, critical revision of manuscript, final approval of version to be published. SKS: designed treatment plan and clinical recommendations, analysis of current literature as it relates to case, drafting manuscript, critical revision of manuscript, final approval of version to be published.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors RJP: analysis of current literature as it relates to case, drafting manuscript, critical revision of manuscript, final approval of version to be published. MAL: critical revision of manuscript, final approval of version to be published. AA: designed treatment plan and clinical recommendations, critical revision of manuscript, final approval of version to be published. SKS: designed treatment plan and clinical recommendations, analysis of current literature as it relates to case, drafting manuscript, critical revision of manuscript, final approval of version to be published.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.